IP Library Granted Patent US 9,020,607
Granted Patent B2
US 9,020,607 · App. 14/315,869 · Granted Apr 28, 2015

Implantable multi-electrode device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,020,607
App. No.
14/315,869
Granted
Apr 28, 2015
Kind
B2
Abstract

The invention provides an implantable multi-electrode device ( 300 ) and related methods and apparatuses. In one embodiment, the invention includes an implantable device ( 300 ) comprising: an assembly block ( 320 ); and a plurality of leads ( 340 . . . 348 ) radiating from the assembly block ( 320 ), each of the plurality of leads ( 340 . . . 348 ) containing at least one electrode ( 342 A), such that the electrodes are distributed within a three-dimensional space, wherein the assembly block ( 320 ) includes a barb ( 350 ) for anchoring the assembly block ( 320 ) within implanted tissue.

Claims (18)

1. A method for delivering an electrical stimulus to an individual, the method comprising administering the electrical stimulus to a tissue of the individual via an implantable medical device, the implantable medical device comprising:

an assembly block; and

a plurality of leads extending from the assembly block, wherein each of the plurality of leads includes at least one electrode, wherein the plurality of leads are configured such that the at least one electrode of each of the plurality of leads are distributed within a three-dimensional tissue space, wherein the assembly block and the plurality of leads are contained within a biodegradable encapsulant during implantation of the implantable medical device such that the at least one electrode of each of the plurality of leads assume a first distribution within the biodegradable encapsulant, and wherein the at least one electrode of each of the plurality of leads are configured to assume a second distribution upon degradation of the biodegradable encapsulant.

2. The method of claim 1 , wherein the assembly block includes at least one barb for anchoring the assembly block within the tissue.

3. The method of claim 2 , wherein the at least one barb is configured to be retracted toward the assembly block in a first position and extend from the assembly block in a second position.

4. The method of claim 1 , wherein at least one of the plurality of leads includes more than one electrode.

5. The method of claim 1 , wherein the biodegradable encapsulant is configured to protect the implantable medical device during implantation.

6. The method of claim 5 , wherein the encapsulant includes at least one of the following: polylactic acid (PLA), polyglycolic acid (PGA), polydioxanone (PDS), polyethylene glycol (PEG), and polyhydroxy butyrate (PHB).

7. The method of claim 1 , wherein the plurality of leads are prearranged such that the distribution of the electrodes corresponds to targeted volume of the tissue.

8. The method of claim 1 , wherein administering includes administering the electrical stimulus to a volume of the tissue smaller than a maximum volume possible by using fewer electrodes than are contained within the plurality of leads.

9. The method of claim 1 , further comprising

recording neural activity within the three-dimensional tissue space using at least one of the electrodes.

10. The method of claim 1 , wherein the electrical stimulus is configured to reduce a tremor suffered by the individual.

11. The method of claim 10 , further comprising

administering to the individual at least one anti-tremor medication.

12. The method of claim 1 , wherein the individual is suffering from at least one of the following: Parkinson's Disease, depression, a bipolar disorder, an obsessive convulsive disorder and epilepsy.

13. The method of claim 1 , further comprising implanting an implantable medical device in the patient.

14. The method claim 1 , wherein the encapsulant includes an anti-inflammatory compound configured to be released while the encapsulant degrades.

Assignments (3)
MERGER Recorded Sep 24, 2015
From: SAPIENS STEERING BRAIN STIMULATION B.V.
To: MEDTRONIC BAKKEN RESEARCH CENTER B.V.
Reel/Frame 036675/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2014
From: MERZ, MATTHIAS; PONOMAREV, YOURI V.; PIJNENBURG, REMCO H.W.
To: KONINKLIJKE PHILIPS ELECTRONICS, N.V.
Reel/Frame 033187/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2014
From: KONINKLIJKE PHILIPS ELECTRONICS, N.V.
To: SAPIENS STEERING BRAIN STIMULATION B.V.
Reel/Frame 033245/0423 →